CytoDyn Market Cap

CytoDyn has a market cap or net worth of $367.12 million as of February 21, 2025. Its market cap has increased by 130.04% in one year.

Market Cap

367.12M

Enterprise Value

374.52M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.30

Market Cap Chart

Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 367.12M, an increase of 6,529.62%. That is a compound annual growth rate of 24.31%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	367.12M	172.68%
Dec 31, 2024	134.63M	-29.42%
Dec 29, 2023	190.74M	2.63%
Dec 30, 2022	185.85M	-72.64%
Dec 31, 2021	679.28M	-78.86%
Dec 31, 2020	3.21B	695.20%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	2.16B
SS Innovations International	1.72B
Nika Pharmaceuticals	1.02B
Veradigm	905.51M
Elite Pharmaceuticals	509.35M
Glass House Brands	499.07M
Northwest Biotherapeutics	338.61M
Silence Therapeutics	236.07M

Market Cap Rankings